US Patent Issued to Orphalan on June 23 for "Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use" (British Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,445, issued on June 23, was assigned to Orphalan SA (Paris).

"Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use" was invented by Timothy James Morley (Harrogate, Great Britain), Ronnie Maxwell Lawrence (Upper Gravenhurst, Great Britain) and Naseem Amin (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes a new crystalline form of triethylenetetramine tetrachloride which has improved room temperature stability over known forms and over the dichloride salt. The new crystalline form is characterised by having peaks in an XRPD spectrum at 22.9, 25.4, 25.8, 26.6, 34.6 and 35.3plus-min...